Nationwide Qui Tam Law Firm on Twitter!
  False Claims Act Law Firm, Boston, Los Angeles, Delaney Kester LLP What is the False Claims Act? The Big Picture - Qui Tam versus Employment Litigation Notable Qui Tam Cases Do you have a False Claims Case? False Claims Act News, Blog Contact Nationwide False Claims Act, Qui Tam Lawyers
Qui Tam Law Firm, False Claims Act Lawyers, Delaney Kester LLP, Boston, Massachusetts, Los Angeles, California
Delaney Kester LLP
Qui Tam and False Claims Act Attorney


Ilyas J. Rona, Of Counsel

Ilyas J. Rona works with Delaney Kester out of its Boston office. For well over a decade, Mr. Rona has been helping relators obtain multi-million dollar recoveries in their False Claims Acts cases.

Mr. Rona concentrates primarily on health care fraud cases, including prescription drug marketing cases, medical device cases, and cases involving illegal conduct by pharmacies, compounding pharmacies, and specialty pharmacies. Mr. Rona also has experience with cases involving fraudulent billing and reimbursement by hospitals and other health care providers. He has investigated and helped uncover numerous illegal practices, including up-coding, bundling and un-bundling, billing for services never received, kickbacks, and lack of medical necessity. Mr. Rona devotes much of his time to obtaining and analyzing evidence in False Claims Acts cases. In most lucrative fraud cases, the scheme is massive and the necessary proof is scattered across millions of pages of documents.

Mr. Rona’s most notable qui tam representations include:

  • Mr. Rona conducted the discovery in a non-intervened qui tam case against Pfizer relating to the off-label marketing of the drug Detrol. Mr. Rona took the depositions of current and former employees of Pfizer and was primarily responsible for finding the key documents within a database of 1 million pages. His depositions and these key documents substantiated the relators’ claims of off-label marketing. As a result, Pfizer agreed to a $25 million settlement to settle the allegations of false claims.
  • Mr. Rona assisted a whistleblower in litigating a non-intervened qui tam case against Pfizer for its off-label marketing of the drug Neurontin. The qui tam action resulted a $430 million settlement with Pfizer. 

Ilyas J. Rona was a Finalist for the 2011 Public Justice Trial Lawyer of the Year Award. He has also been asked to give lectures, including:

  • Invited Session, “The Legal System: Evidence-Based Medicine's Last Stand?” Society for Clinical Trials, Annual Meeting in Vancouver, B.C., May 17, 2011
  • Panelist, “Causation, Damages & Settlement Negotiations.” Current Topics and Recent Developments in False Claims Act Litigation, Suffolk University School of Law—Continuing Legal Education (ALS) in Boston, MA, March 31, 2011

Mr. Rona has also authored various publications, including:

  • Rona, “The Whistleblower Perspective: Why They Do It, and Why We Need Them.” Current Topics and Recent Developments in False Claims Act Litigation. Mar 2011; 361.

Ilyas J. Rona received his J.D. degree from Northwestern University School of Law in 1998, where he was an articles editor of the Journal of Criminal Law and Criminology.  Mr. Rona received his undergraduate education from Brown University, where he graduated magna cum laude in 1995.

Also affiliated with Milligan Coughlin LLC.

Delaney Kester LLP ©2013 | Terms of Use

Email False Claims Act Law Firm